EPHX4 抗体 (AA 36-359)
Quick Overview for EPHX4 抗体 (AA 36-359) (ABIN7616724)
抗原
See all EPHX4 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 36-359
- 
                                            原理
- Epoxide Hydrolase 4 (EPHX4) Polyclonal Antibody
- 
                                            序列
- Lys36~Asp359
- 
                                            产品特性
- The Epoxide Hydrolase 4 (EPHX4) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
- 
                                            纯化方法
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 0.5 mg/mL
- 
                                            缓冲液
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - EPHX4 (Epoxide Hydrolase 4 (EPHX4))
- 
                                            别名
- EPHX4
- 
                                            基因ID
- 384214
- 
                                            UniProt
- Q6IE26
 抗原
- 
                    
 
                                     
                                     
                                    